Skip to main content
    C

    Core Scientific, Inc. Common Stock (CORZ)

    Official site

    TECHNOLOGY • SOFTWARE - INFRASTRUCTURE • NASDAQ

    $13.58
    -0.94 (-6.47%)

    Market Cap: $4.68B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Core Scientific, Inc. Common Stock (CORZ) P/E Ratio & Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Core Scientific, Inc. Common Stock (CORZ) trades at 38.1x trailing earnings and 10.8x sales. Its forward P/E is 19.5x. The median P/E across 7 similar companies is 14.6x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 95.4% higher over the next year.

    MultipleValue
    P/E (trailing)38.1x
    Forward P/E19.5x
    Price to sales10.8x
    PEGN/A
    FCF yield-20.7%

    As of Nov 17, 2026

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CORZ

    What is CORZ's forward P/E ratio?

    Core Scientific, Inc. Common Stock has a forward P/E ratio of 19.5x.

    Is CORZ stock overvalued?

    GNG's valuation label for CORZ is Overvalued. Its P/E of 38.1x compares with a median of 14.6x across 7 similar companies.

    What is CORZ's price to sales ratio?

    Core Scientific, Inc. Common Stock has a price to sales ratio of 10.8x.